Bowling Portfolio Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$1.54M Sell
21,660
-1,406
-6% -$102K 0.42% 74
2022
Q2
$1.78M Sell
23,066
-10,974
-32% -$836K 0.45% 70
2022
Q1
$2.49M Buy
34,040
+10,463
+44% +$703K 0.53% 50
2021
Q4
$1.47M Sell
23,577
-1,241
-5% -$72.8K 0.31% 114
2021
Q3
$1.47M Sell
24,818
-348
-1% -$22.9K 0.33% 118
2021
Q2
$1.68M Sell
25,166
-565
-2% -$36.8K 0.38% 96
2021
Q1
$1.62M Sell
25,731
-27,537
-52% -$1.71M 0.39% 100
2020
Q4
$3.3M Sell
53,268
-3,906
-7% -$240K 0.78% 23
2020
Q3
$3.45M Sell
57,174
-23,757
-29% -$1.43M 0.77% 19
2020
Q2
$4.76M Sell
80,931
-1,119
-1% -$66.9K 1.02% 12
2020
Q1
$4.57M Buy
82,050
+22,821
+39% +$1.39M 1.13% 14
2019
Q4
$3.8M Buy
+59,229
New +$3.39M 0.65% 30
2019
Q2
Sell
-72,501
Closed -$3.46M 322
2019
Q1
$3.46M Sell
72,501
-1,107
-2% -$55.1K 0.55% 39
2018
Q4
$3.83M Sell
73,608
-1,026
-1% -$55.1K 0.68% 24
2018
Q3
$4.63M Sell
74,634
-4,325
-5% -$257K 0.65% 28
2018
Q2
$4.37M Buy
+78,959
New +$4.26M 0.61% 36

Other funds holding BMY

Bowling Portfolio Management's BMY Position: Q3 2022 in Review

Bowling Portfolio Management reduced its Bristol-Myers Squibb (BMY) stake by 6.1% in Q3 2022, selling an estimated $102K and leaving 21,660 shares worth $1.54M. The position accounts for 0.42% of the portfolio, ranked #74.

Bowling Portfolio Management first reported a position in BMY in Q2 2018 and has held it in 16 quarters since. The position peaked at $4.76M in Q2 2020. 2,470 funds tracked by Wall St. Rank hold BMY as of Q3 2022.

  • Bowling Portfolio Management held 21,660 shares of Bristol-Myers Squibb worth $1.54M as of Q3 2022.
  • Bowling Portfolio Management sold 1,406 Bristol-Myers Squibb shares in Q3 2022, an estimated $102K.
  • Bristol-Myers Squibb made up 0.42% of Bowling Portfolio Management's portfolio in Q3 2022, its #74 holding.
  • Bowling Portfolio Management first reported a position in Bristol-Myers Squibb in Q2 2018 and has held it in 16 quarters since.
  • Bowling Portfolio Management's Bristol-Myers Squibb position peaked at $4.76M in Q2 2020.
  • 2,470 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2022.

Based on Bowling Portfolio Management's 13F filing for Q3 2022, filed 4 Oct 2022.